Home › Funds › Hillhouse Capital (HHLR Advisors) › AVBP
Hillhouse Capital (HHLR Advisors) position in AVBP
ARRIVENT BIOPHARMA INC · Health Care
Latest position (Q2 2026)3.93M sh
Reported value held$136.50M
Portfolio Weight16.40%
First reportedQ1 2024
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 3.93M | $70.17M | New |
| Q2 2024 | 4.48M | $83.19M | Add |
| Q3 2024 | 4.48M | $105.39M | Hold |
| Q4 2024 | 4.48M | $119.47M | Hold |
| Q1 2025 | 4.48M | $82.92M | Hold |
| Q2 2025 | 4.48M | $97.63M | Hold |
| Q3 2025 | 4.48M | $82.74M | Hold |
| Q4 2025 | 3.93M | $79.05M | Reduce |
| Q1 2026 | 3.93M | $90.64M | Hold |
| Q2 2026 | 3.93M | $136.50M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AVBP
- BlackRock Inc 3.25M sh · $112.92M · Q2 2026
- Fidelity Management & Research (FMR) 2.78M sh · $96.54M · Q2 2026
- Vanguard Group 1.87M sh · $37.61M · Q4 2025
- Geode Capital Management 972.63K sh · $33.80M · Q2 2026
- D. E. Shaw & Co 872.01K sh · $30.29M · Q2 2026
- Goldman Sachs Group 853.72K sh · $29.66M · Q2 2026
- Point72 Asset Management 566.80K sh · $19.69M · Q2 2026
- Millennium Management 438.66K sh · $15.24M · Q2 2026
- UBS Group AG 438.59K sh · $15.24M · Q2 2026
- Balyasny Asset Management 395.45K sh · $13.74M · Q2 2026
- Northern Trust Corp 332.75K sh · $11.56M · Q2 2026